MX344970B - Medio de cultivo celular para la expresion de la proteina adamts. - Google Patents

Medio de cultivo celular para la expresion de la proteina adamts.

Info

Publication number
MX344970B
MX344970B MX2013009470A MX2013009470A MX344970B MX 344970 B MX344970 B MX 344970B MX 2013009470 A MX2013009470 A MX 2013009470A MX 2013009470 A MX2013009470 A MX 2013009470A MX 344970 B MX344970 B MX 344970B
Authority
MX
Mexico
Prior art keywords
culture medium
cell culture
protein expression
adamts protein
adamts
Prior art date
Application number
MX2013009470A
Other languages
English (en)
Inventor
Grillberger Leopold
Spenger Alexandra
Hasslacher Meinhard
Grillberger Rana
Reiter Manfred
Original Assignee
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta Inc filed Critical Baxalta Inc
Publication of MX344970B publication Critical patent/MX344970B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/22—Zinc; Zn chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)

Abstract

La presente invención se refiere a un método para producir una composición ADAMTS, el método comprende los pasos de: (a) cultivar una célula que contiene un ácido nucleico que codifica una proteína ADAMTS en un medio de cultivo libre de proteína animal; (b) eliminar una fracción del sobrenadante del cultivo; (c) realizar una etapa de filtración o centrifugación para eliminar cualquier célula residual; (d) realizar una etapa de ultrafiltración para concentrar la proteína ADAMTS; y ( e) realizar una etapa de diafiltración un amortiguador que comprende al menos aproximadamente 0.5 µM de zinc y al menos aproximadamente 0.1 mM de calcio; preparando de ese modo una composición ADAMTS.
MX2013009470A 2009-07-31 2012-01-27 Medio de cultivo celular para la expresion de la proteina adamts. MX344970B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23047709P 2009-07-31 2009-07-31

Publications (1)

Publication Number Publication Date
MX344970B true MX344970B (es) 2017-01-12

Family

ID=42668009

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012001261A MX2012001261A (es) 2009-07-31 2010-07-30 Medio de cultivo de celula para la expresion de proteina adamts.
MX2013009470A MX344970B (es) 2009-07-31 2012-01-27 Medio de cultivo celular para la expresion de la proteina adamts.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2012001261A MX2012001261A (es) 2009-07-31 2010-07-30 Medio de cultivo de celula para la expresion de proteina adamts.

Country Status (22)

Country Link
US (7) US8313926B2 (es)
EP (1) EP2459702B1 (es)
JP (5) JP5451884B2 (es)
KR (5) KR101912552B1 (es)
CN (2) CN104962539B (es)
AU (1) AU2010278751B2 (es)
BR (2) BR122021005965B1 (es)
CA (1) CA2769361A1 (es)
CO (1) CO6501191A2 (es)
EA (1) EA023193B1 (es)
ES (1) ES2583258T3 (es)
HK (1) HK1171790A1 (es)
HR (1) HRP20160783T1 (es)
HU (1) HUE029110T2 (es)
IN (1) IN2012DN00801A (es)
MX (2) MX2012001261A (es)
NZ (1) NZ597727A (es)
PL (1) PL2459702T3 (es)
PT (1) PT2459702T (es)
SG (1) SG178194A1 (es)
SI (1) SI2459702T1 (es)
WO (1) WO2011014838A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG178194A1 (en) * 2009-07-31 2012-03-29 Baxter Int Cell culture medium for adamts protein expression
EA035147B1 (ru) 2010-07-08 2020-05-06 Баксалта Инкорпорейтид Способ получения рекомбинантного adamts13 в культуре клеток
ES2625045T3 (es) 2011-07-01 2017-07-18 Amgen Inc. Cultivo de células de mamífero
CN104822826B (zh) 2012-10-15 2019-04-30 百时美施贵宝公司 用于蛋白产生的哺乳动物细胞培养过程
US9611455B2 (en) 2013-03-13 2017-04-04 Merck Sharp & Dohme Corp. Adapted lepidopteran insect cells for the production of recombinant proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
CA2926517C (en) * 2013-10-14 2021-03-23 Ares Trading S.A. New medium for high performance mammalian fed-batch cultures
BR112016028285B1 (pt) 2014-06-04 2023-02-23 Amgen Inc Método para uma colheita periódica prolongada, sistema de filtro de unidade única e método para cultivo de células que expressam proteína recombinante
KR101867134B1 (ko) * 2015-03-23 2018-06-12 한양대학교 산학협력단 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법
DK3298138T3 (da) * 2015-05-22 2022-10-31 Dupont Nutrition Biosci Aps Acetolactatdecarboxylase
TW202330904A (zh) 2015-08-04 2023-08-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
CA3031740A1 (en) 2016-08-04 2018-02-08 Baxalta Incorporated Use of adamts13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
KR102482744B1 (ko) * 2016-11-04 2022-12-30 다케다 야쿠힌 고교 가부시키가이샤 아데노-연관 바이러스 정제 방법
MX2020009605A (es) * 2018-03-16 2021-01-08 Genzyme Corp Metodos para mejorar la viabilidad celular en un biorreactor de produccion.
US20210189358A1 (en) * 2018-06-18 2021-06-24 Synthetic Biologics, Inc. Methods of making alkaline phosphatase agents
BR112021025769A2 (pt) 2019-12-06 2022-04-12 Regeneron Pharma Composições de proteína anti-vegf e métodos para a produção das mesmas
JP2023521658A (ja) 2020-04-02 2023-05-25 武田薬品工業株式会社 Ａｄａｍｔｓ１３バリアント、組成物、及びその使用
WO2021234458A1 (en) 2020-05-22 2021-11-25 Takeda Pharmaceutical Company Limited Adamts13 compositions and methods for treating and diagnosing complications of coronavirus disease
CN111808822B (zh) * 2020-07-02 2024-01-12 北京百普赛斯生物科技股份有限公司 细胞培养用补料液及提高重组hek293细胞蛋白表达量的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
CZ280901B6 (cs) 1988-10-06 1996-05-15 Hideaki Yamada Způsob kultivace bakterií
JPH0753104B2 (ja) * 1989-02-28 1995-06-07 秀明 山田 細菌の培養法
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
WO1996015231A2 (en) 1994-11-10 1996-05-23 Immuno Aktiengesellschaft Method for producing biologicals in protein-free culture
JP3649249B2 (ja) 1995-02-23 2005-05-18 クエスト・インターナショナル・サービシーズ・ビー・ブイ 組織および細胞培養用ペプチド
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
IT1285158B1 (it) 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
WO1998015514A1 (en) 1996-10-07 1998-04-16 Solutia Inc. Process for the hydroxylation of benzene
WO1998015614A1 (en) 1996-10-10 1998-04-16 Life Technologies, Inc. Animal cell culture media comprising plant-derived nutrients
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6926894B2 (en) * 2000-11-22 2005-08-09 Baxter Aktiengesellschaft Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
WO2004056976A2 (en) 2002-12-23 2004-07-08 Fuji Photo Film B.V. Process for coating cell-culture support
EP1737953A2 (en) * 2004-04-16 2007-01-03 Wyeth a Corporation of the State of Delaware Adamts-8 proteins and uses thereof
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
JP2007174948A (ja) * 2005-12-27 2007-07-12 Noritsu Koki Co Ltd 酵素水製造装置
JP4880997B2 (ja) * 2005-12-28 2012-02-22 アルフレッサファーマ株式会社 Ａｄａｍｔｓ１３の安定化方法
PL2522717T3 (pl) 2006-01-04 2014-08-29 Baxalta Inc Pożywki do hodowli komórkowych wolne od oligopeptydów
CN101611268B (zh) * 2006-12-22 2013-06-12 斯普灵格开利有限公司 用于空调单元的新鲜空气控制杆
US20090067805A1 (en) 2007-09-10 2009-03-12 Victor Company Of Japan, Limited Recording and reproducing device
PL2574676T3 (pl) * 2007-12-27 2017-12-29 Baxalta GmbH Sposoby hodowli komórek
SG178194A1 (en) * 2009-07-31 2012-03-29 Baxter Int Cell culture medium for adamts protein expression

Also Published As

Publication number Publication date
PL2459702T3 (pl) 2016-12-30
HUE029110T2 (en) 2017-02-28
CN102549145B (zh) 2015-05-20
JP5936232B2 (ja) 2016-06-22
KR101573972B1 (ko) 2015-12-02
JP7083059B2 (ja) 2022-06-09
PT2459702T (pt) 2016-08-02
BR112012002151A2 (pt) 2020-03-03
KR20170081747A (ko) 2017-07-12
JP2013500724A (ja) 2013-01-10
CN104962539B (zh) 2019-09-17
KR101574056B1 (ko) 2015-12-02
CO6501191A2 (es) 2012-08-15
KR101912552B1 (ko) 2018-10-26
ES2583258T3 (es) 2016-09-20
KR20120046301A (ko) 2012-05-09
KR101756354B1 (ko) 2017-07-26
US20190071660A1 (en) 2019-03-07
JP2014061005A (ja) 2014-04-10
JP2016144471A (ja) 2016-08-12
JP2021112210A (ja) 2021-08-05
KR20150138425A (ko) 2015-12-09
MX2012001261A (es) 2012-05-22
IN2012DN00801A (es) 2015-06-26
US20130071906A1 (en) 2013-03-21
US20110086413A1 (en) 2011-04-14
CN104962539A (zh) 2015-10-07
HRP20160783T1 (hr) 2016-08-12
SI2459702T1 (sl) 2016-11-30
US10724024B2 (en) 2020-07-28
US9441216B2 (en) 2016-09-13
JP2018093881A (ja) 2018-06-21
EP2459702A1 (en) 2012-06-06
BR112012002151B1 (pt) 2021-07-06
US20200308566A1 (en) 2020-10-01
EA023193B1 (ru) 2016-05-31
WO2011014838A1 (en) 2011-02-03
AU2010278751B2 (en) 2014-05-15
BR122021005965B1 (pt) 2022-01-25
KR101808496B1 (ko) 2017-12-12
US20170051270A1 (en) 2017-02-23
EP2459702B1 (en) 2016-05-04
US20150329848A1 (en) 2015-11-19
JP6883071B2 (ja) 2021-06-09
JP5451884B2 (ja) 2014-03-26
US20140329294A1 (en) 2014-11-06
CA2769361A1 (en) 2011-02-03
JP2019201661A (ja) 2019-11-28
HK1171790A1 (zh) 2013-04-05
US11254921B2 (en) 2022-02-22
KR20150044981A (ko) 2015-04-27
CN102549145A (zh) 2012-07-04
US10072254B2 (en) 2018-09-11
AU2010278751A1 (en) 2012-02-09
JP6511007B2 (ja) 2019-05-08
EA201270224A1 (ru) 2012-09-28
JP6567707B2 (ja) 2019-08-28
SG178194A1 (en) 2012-03-29
KR20170140411A (ko) 2017-12-20
US9127265B2 (en) 2015-09-08
NZ597727A (en) 2013-08-30
US8759026B2 (en) 2014-06-24
US8313926B2 (en) 2012-11-20

Similar Documents

Publication Publication Date Title
MX344970B (es) Medio de cultivo celular para la expresion de la proteina adamts.
IN2012DN03825A (es)
MX2010000348A (es) Cultivo de celulas madre pluripotentes individuales.
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2011133902A3 (en) Cell culture medium comprising small peptides
WO2012019122A3 (en) Simplified basic media for human pluripotent cell culture
MX2010008099A (es) Anticuerpos y angiopoyetina-2 estabilizados y sus usos.
WO2010141801A3 (en) Reprogramming t cells and hematophietic cells
EA201270151A1 (ru) Способы и композиции для рекомбинантного биосинтеза h-алканов
MX2012001742A (es) Produccion de proteinas en medios de cultivo de celulas libres de glutamina.
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
CO6680636A2 (es) Método para producir adamts13 recombinante en cultivo celular
MX2009007632A (es) Precipitacion de polielectrolito y purificacion de proteinas.
SG196784A1 (en) Stem cell cultures
PH12020500027A1 (en) Purification of iduronate-2-sulfatase
WO2011075686A3 (en) Methods & compositions comprising heat shock proteins
WO2012024573A3 (en) Compositions comrpising perivascular stem cells and nell-1 protein
EA201590312A1 (ru) Ферменты
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
MX349801B (es) Sustratos de enzimas de ácido nucleico.
WO2009058451A3 (en) Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction
WO2008085956A3 (en) High expression cell line that eliminates gene amplification